Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Testosterone Enanthate
Testosterone Enanthate
Inquiry
| Post Date: | May 08,2013 |
| Expiry Date: | Nov 04,2013 |
| Detailed Description: |
Cas No. :CAS: 315-37-7
Quantity: 100 Specs: 98% min. Price:1 USD Metric Tons Payment Method: t/t Testosterone Enanthate Synonyms: testosterone enantate; testosterone enthanoate CAS: 315-37-7 EINECS: 206-253-5 Assay: 98% min. Packing: foil bag or tin. Delivery: Express courier. Character: White crystalline powder. Mp 34-39℃, refractive index 77°. Usage: Pharmaceutical material, Steroid hormone, Anabolin. Clinically for the treatment of male sexual function decline, aplastic anemia and other illnesses. Indications and Usage for Testosterone Enanthate Hypogonadotropic hypogonadism (congenital or acquired) - Idiopathic gonadotropin or luteinizing hormone‑releasing hormone (LHRH) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. (Appropriate adrenal cortical and thyroid hormone replacement therapy are still necessary, however, and are actually of primary importance.) If the above conditions occur prior to puberty, androgen replacement therapy will be needed during the adolescent years for development of secondary sexual characteristics. Prolonged androgen treatment will be required to maintain sexual characteristics in these and other males who develop testosterone deficiency after puberty. Delayed puberty - Testosterone Enanthate Injection, USP may be used to stimulate puberty in carefully selected males with clearly delayed puberty. These patients usually have a familial pattern of delayed puberty that is not secondary to a pathological disorder; puberty is expected to occur spontaneously at a relatively late date. Brief treatment with conservative doses may occasionally be justified in these patients if they do not respond to psychological support. The potential adverse effect on bone maturation should be discussed with the patient and parents prior to androgen administration. An X-ray of the hand and wrist to determine bone age should be obtained every six months to assess the effect of treatment on the epiphyseal centers (see WARNINGS). Contraindications Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant. When administered to pregnant women, androgens cause virilization of the external genitalia of the female fetus. This virilization includes Warnings In patients with breast cancer and in immobilized patients, androgen therapy may cause hypercalcemia by stimulating osteolysis. In patients with cancer, hypercalcemia may indicate progression of bony metastasis. If hypercalcemia occurs, the drug should be discontinued and appropriate measures instituted. Prolonged use of high doses of androgens has been associated with the development of peliosis hepatis and hepatic neoplasms including hepatocellular carcinoma (see PRECAUTIONS, Carcinogenesis). Peliosis hepatis can be a life-threatening or fatal complication. If cholestatic hepatitis with jaundice appears or if liver function tests become abnormal, the androgen should be discontinued and the etiology should be determined. Drug-induced jaundice is reversible when the medication is discontinued. Our company can supply many high-quality products . Welcome to inquiry and detailed information would be given.Our products list: Testosterone Base Methyltestosterone Testosterone Propionate Testosterone decanoate Testosterone Undecanoate Testosterone Cypionate Testosterone isocaproate Testosterone Enanthate Mesterolone Testosterone Phenylpropionate 17a-Methyl-1-testosterone 4-Chlorotestosterone Acetate Sustanon250 powder(mixed testosterone) Clostebol Acetate Testosterone Acetate Boldenone Cypionate Boldenone Boldenone undecylenate Boldenone Acetate ester Boldenone Acetate Nandrolone Nandrolone Phenylpropionate Nandrolone Decanoate Mestanolone Drostanolone Enanthate Drostanolone propionate(Masteron) Oxandrolone(anavar) Oxymetholone(Anadrol) Metandienone(Dianabol) Stanozolol(winstrol) Trenbolone Enanthate Trenbolone Acetate Methenolone Enanthate Methenolone Acetate Chlordehydromethyltestosterone(Turinabol) Dutasteride Finasteride Tamoxifen Citrate(Nolvadex) Raloxifene Tamoxifen Clomifene citrate(cClomiphene) Vardenafil Sildenafil Exemestane( Aromasin) Epiandrosterone |
| CAS Registry Number: | CAS: 315-37-7 |
| Synonyms: | ;testosterone enantate;testosterone enthanoate;(17beta)-3-oxoandrost-4-en-17-yl heptanoate; |
| Molecular Formula: | C26H41O3 |
| Molecular Weight: | 401.6025 |
| Molecular Structure: | 
|
| Company: | Shenzhen ShiJinGu Technology Co., Ltd [ China ] |
| Contact: | sharon |
| Tel: | 0755-61930360 |
| Fax: | 0755-84556470 |
| Email: | zc06@yccreate.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
